Rationally designed antibodies

Details for Australian Patent Application No. 2002234001 (hide)

Owner Alexion Pharmaceuticals, Inc.

Inventors Renshaw, Mark; Barbas-Frederickson, Shana; Bowdish, Katherine S.

Agent Freehills

Pub. Number AU-B-2002234001

PCT Pub. Number WO02/46238

Priority 60/288,889 04.05.01 US; 60/294,068 29.05.01 US; 60/251,448 05.12.00 US

Filing date 5 December 2001

Wipo publication date 18 June 2002

Acceptance publication date 1 May 2008

International Classifications

C07K 14/505 (2006.01) Peptides having more than 20 amino acids

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

1 May 2008 Application Accepted

  Published as AU-B-2002234001

28 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002234002

2002234000